Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10071/27561 |
Resumo: | One of the biggest challenges of this decade has been the consequences caused by one of the world's biggest disruptions in healthcare. Supply chains have proven that flexibility is key to ensuring the health of their patients, and evidence of an insufficiently flexible supply chain can have serious consequences on the global economy and state of health. The situation is worsened when dealing directly with biological raw materials, where time is counted in detail and their delivery deadlines must be met. The role of this dissertation is to demonstrate the need to introduce new management strategy models in the area and apply measures that assist members of the organisation and their stakeholders in facing challenges and unlikely scenarios to ensure that patients are never harmed at the end of the chain due to a lack of raw materials and materials in production because suppliers have failed to meet demand. Through the mixed methods research methods, it was possible to understand the opportunity to implement strategies linked to organisational ambidexterity, the tension of exploration and exploitation, and to adopt strategic measures beneficial to supply chain flexibility. After the foundation and analysis offered by the questionnaires and interviews, it was possible to foresee an increasing concern to develop better relationships with suppliers and enjoy the established relationships. Therefore, the exploitation of suppliers in the supply chain reveals great importance as it is a recent theme and it is with this value that one seeks to induce discussion. |
id |
RCAP_0214f5ca931dd06559ef59d3a265f6f2 |
---|---|
oai_identifier_str |
oai:repositorio.iscte-iul.pt:10071/27561 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibilityOrganizational ambidexterityCadeia de abastecimento -- Supply chainBiopharmaceuticalFlexibilitySuppliersAmbidestria organizacionalBiofarmacêuticaFlexibilidadeFornecedorOne of the biggest challenges of this decade has been the consequences caused by one of the world's biggest disruptions in healthcare. Supply chains have proven that flexibility is key to ensuring the health of their patients, and evidence of an insufficiently flexible supply chain can have serious consequences on the global economy and state of health. The situation is worsened when dealing directly with biological raw materials, where time is counted in detail and their delivery deadlines must be met. The role of this dissertation is to demonstrate the need to introduce new management strategy models in the area and apply measures that assist members of the organisation and their stakeholders in facing challenges and unlikely scenarios to ensure that patients are never harmed at the end of the chain due to a lack of raw materials and materials in production because suppliers have failed to meet demand. Through the mixed methods research methods, it was possible to understand the opportunity to implement strategies linked to organisational ambidexterity, the tension of exploration and exploitation, and to adopt strategic measures beneficial to supply chain flexibility. After the foundation and analysis offered by the questionnaires and interviews, it was possible to foresee an increasing concern to develop better relationships with suppliers and enjoy the established relationships. Therefore, the exploitation of suppliers in the supply chain reveals great importance as it is a recent theme and it is with this value that one seeks to induce discussion.Um dos maiores desafios desta década foi as consequências provocadas por uma das maiores disrupções mundiais na área da saúde. As cadeias de abastecimento provaram que a flexibilidade é fundamental para assegurar a saúde dos seus pacientes e as evidências de uma cadeia de abastecimento pouco flexível podem ter consequências graves na economia e no estado da saúde mundial. A situação agrava-se quando se lida diretamente com matéria-prima biológica, onde o tempo é contabilizado ao detalhe e os seus prazos de entrega têm de ser cumpridos. O papel desta dissertação é demonstrar a necessidade de introduzir novos modelos de estratégia da gestão na área e aplicar medidas que auxiliem os membros da organização e os seus envolventes a enfrentarem desafios e cenários improváveis para garantir que os pacientes nunca sejam prejudicados no final da cadeia, devido à falta de matéria-prima e materiais na produção porque fornecedores não conseguiram atender a procura. Através dos métodos de pesquisa de métodos mistos foi possível compreender a oportunidade de implementação de estratégias ligadas à ambidestria organizacional, a tensão da exploração e exploração, para adotar medidas estratégicas beneficiais à flexibilidade da cadeia de abastecimento. Após os fundamentos e análise oferecida pelos questionários e entrevistas foi possível prever uma crescente preocupação em desenvolver melhores relacionamentos com os fornecedores e usufruir das relações estabelecidas. Portanto, a exploração dos fornecedores na cadeia de abastecimento revela grande importância por se tratar de um tema recente e é com esse valor que se procura induzir à discussão.2023-12-21T00:00:00Z2022-12-21T00:00:00Z2022-12-212022-11info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10071/27561TID:203179803engFaria, Inês Maria Velosoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-24T01:18:04Zoai:repositorio.iscte-iul.pt:10071/27561Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:13:47.315298Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
title |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
spellingShingle |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility Faria, Inês Maria Veloso Organizational ambidexterity Cadeia de abastecimento -- Supply chain Biopharmaceutical Flexibility Suppliers Ambidestria organizacional Biofarmacêutica Flexibilidade Fornecedor |
title_short |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
title_full |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
title_fullStr |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
title_full_unstemmed |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
title_sort |
Organizational ambidexterity in biopharmaceuticals’ supply chain flexibility |
author |
Faria, Inês Maria Veloso |
author_facet |
Faria, Inês Maria Veloso |
author_role |
author |
dc.contributor.author.fl_str_mv |
Faria, Inês Maria Veloso |
dc.subject.por.fl_str_mv |
Organizational ambidexterity Cadeia de abastecimento -- Supply chain Biopharmaceutical Flexibility Suppliers Ambidestria organizacional Biofarmacêutica Flexibilidade Fornecedor |
topic |
Organizational ambidexterity Cadeia de abastecimento -- Supply chain Biopharmaceutical Flexibility Suppliers Ambidestria organizacional Biofarmacêutica Flexibilidade Fornecedor |
description |
One of the biggest challenges of this decade has been the consequences caused by one of the world's biggest disruptions in healthcare. Supply chains have proven that flexibility is key to ensuring the health of their patients, and evidence of an insufficiently flexible supply chain can have serious consequences on the global economy and state of health. The situation is worsened when dealing directly with biological raw materials, where time is counted in detail and their delivery deadlines must be met. The role of this dissertation is to demonstrate the need to introduce new management strategy models in the area and apply measures that assist members of the organisation and their stakeholders in facing challenges and unlikely scenarios to ensure that patients are never harmed at the end of the chain due to a lack of raw materials and materials in production because suppliers have failed to meet demand. Through the mixed methods research methods, it was possible to understand the opportunity to implement strategies linked to organisational ambidexterity, the tension of exploration and exploitation, and to adopt strategic measures beneficial to supply chain flexibility. After the foundation and analysis offered by the questionnaires and interviews, it was possible to foresee an increasing concern to develop better relationships with suppliers and enjoy the established relationships. Therefore, the exploitation of suppliers in the supply chain reveals great importance as it is a recent theme and it is with this value that one seeks to induce discussion. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-21T00:00:00Z 2022-12-21 2022-11 2023-12-21T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10071/27561 TID:203179803 |
url |
http://hdl.handle.net/10071/27561 |
identifier_str_mv |
TID:203179803 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134694845972480 |